Circulating Tumor Cell (CTC) Diagnostics Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Global Circulating Tumor Cell (CTC) Diagnostics Market is expected to grow at CAGR of 19% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Circulating Tumor Cell (CTC) Diagnostics Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:

KEY PLAYERS

ADNAGEN AG

ADVANCED CELL DIAGNOSTICS

APOCELL INC.

AVIVA BIOSCIENCES

BIOCEPT INC.

BIOCEP LTD

BIOFLUIDICA INC

CANOPUS BIOSCIENCE LTD.

CELLTRAFFIX INC.

CLEARBRIDGE BIOMEDICS PTE LTD.

CREATV MICROTECH INC.

CYNVENIO BIOSYSTEMS, INC.

EPIC SCIENCES INC.

FLUXION BIOSCIENCES INC.

IKONISYS INC.

IV DIAGNOSTICS INC.

JANSSEN DIAGNOSTICS/VERIDEX

MILTENYI BIOTECH GMBH

NANOSTRING TECHNOLOGIES INC.

RARECELLS DIAGNOSTICS

SCREENCELL

SILICON BIOSYSTEMS

STEMCELL TECHNOLOGIES

SYSMEX CORPORATION

VITATEX INC

Scope of the Market

Technology Market

CTC Enrichment

CTC Detection

CTC Analysis

Application Market

Tumorigenesis research

EMT biomarkers development

Cancer stem cell research

Others

Geography Market

North America

Europe

Asia Pacific

Rest of the World (RoW)

Back to top

Payment Options

Single User : $3,897
Five User: $5,175
Enterprise : $9,135
Datapack : $1,299
Short Report : $1,799